Historia de las espondiloartropatías seronegativas - Revista ...
Historia de las espondiloartropatías seronegativas - Revista ...
Historia de las espondiloartropatías seronegativas - Revista ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ANTONIO IGLESIAS GAMARRA & Cols.<br />
186. Maksymowych WP, Jhangri GS, Fitzgerald AA, et al. A<br />
six-month randomized controlled, double-blind, doseresponse,<br />
comparison of intravenous pamidronate, (60 mg<br />
versus 10 mg) in the treatment of nonsteroidal antiinflammatory<br />
drug-refractory ankylosing spondylitis.<br />
Arthritis Rheum 2002; 46: 766-773.<br />
187. Mease PJ, Goffe BS, Metz J, Van<strong>de</strong>rStoep A, Ficck B, Buerge<br />
DJ. Etanercept in the treatment of psoriatic arthritis and<br />
psoriasis: a randomized trial. Lancet 2000; 356: 385-390.<br />
198<br />
REVISTA COLOMBIANA DE REUMATOLOGÍA<br />
188. Braun J, Brand J, Listing J, et al. Treatment of active<br />
ankylosing spondylitis with infliximab: A randomized<br />
controlled multicenter trial. Lancet 2002; 359: 1187-<br />
1193.<br />
189. Van <strong>de</strong> Bosch F, Kruithof E, Beaten D, et al. Randomized<br />
double-blind comparison of chimeric monoclonal antibody<br />
to tumor necrosis factor alpha (infliximab) versus placebo<br />
in active spodyloarthropathy. Arthritis Rheum 2002; 46:<br />
755-765.
Change language